PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu Province, China.\', \'Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.\', \'Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu Province, China. jingxin110@sina.com.\', \'Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu Province, China. wuyanhu@njmu.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00228-020-03017-5
?:doi
?:hasPublicationType
?:journal
  • European journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33051695
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.159
?:rankingScore_hIndex
  • 96
?:title
  • Tocilizumab for treating COVID-19: a systemic review and meta-analysis of retrospective studies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all